← Return to Using pulsating electro-magnetic fields as an adjunct in treating CLL

Discussion

Using pulsating electro-magnetic fields as an adjunct in treating CLL

Blood Cancers & Disorders | Last Active: Dec 18, 2018 | Replies (6)
Comment receiving replies
@bullwinkle

I may be in a trial which would consist of either Venetoclax,Ibrutinib, and gazyva or Ibrutinib and gazyva. I did the PEMF on my own. It is interesting to note that my Leukocyte count in April was 152 and my LDH was 416. I just returned from Mayo's and after 7 months my leukocyte count is 125 and my LDH is 358. Not something you would expect with my diagnosis.

Jump to this post

Replies to "I may be in a trial which would consist of either Venetoclax,Ibrutinib, and gazyva or Ibrutinib..."
ckeys | @ckeys | Dec 13, 2018

@bullwinkle Seems like this is a perfect example of finding the right prescription that suits our particular case. Wishing you best of luck with your future treatments. Thank you for sharing your experiences.

VIEW AND REPLY